Microcirculation First!-Esmolol, a Candidate for the Next Term of Office

Crit Care Med. 2017 Dec;45(12):2115-2116. doi: 10.1097/CCM.0000000000002757.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists
  • Endotoxemia*
  • Humans
  • Microcirculation
  • Propanolamines*

Substances

  • Adrenergic beta-Antagonists
  • Propanolamines
  • esmolol